Skip to content
CancerIndex

Publication

Association of time to upfront treatment initiation with outcomes in metastatic hormone-sensitive prostate cancer: a 4-month landmark analysis.

Eisuke Iwaori, Takafumi Yanagisawa, Shintaro Narita, Wataru Fukuokaya, Fumihiko Urabe, Naoki Fujita, Hiromi Sato, Tomoko Hamaya, Takuma Narita, Teppei Okamoto, Tomonori Habuchi, Takahiro Kimura, Shingo Hatakeyama

World journal of urologySep 25, 2026PMID 42789110doi:10.1007/s00345-026-06800-8 Journal ArticleMulticenter StudypubmedProvenance
Source
PubMed
Retrieved
Sep 28, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260928-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND: The clinical significance of variation in the timing of treatment intensification after androgen deprivation therapy (ADT) initiation in metastatic hormone-sensitive prostate cancer (mHSPC) remains unclear. We evaluated whether time to upfront treatment initiation was associated with…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.